These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4772979)

  • 1. Pharmacokinetics of glipizide in man: influence of renal insufficiency.
    Balant L; Zahnd G; Gorgia A; Schwarz R; Fabre J
    Diabetologia; 1973 Sep; ():331-8. PubMed ID: 4772979
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic.
    Schmidt HA; Schoog M; Schweer KH; Winkler E
    Diabetologia; 1973 Sep; ():320-30. PubMed ID: 4772978
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide.
    Fuccella LM; Tamassia V; Valzelli G
    J Clin Pharmacol New Drugs; 1973; 13(2):68-75. PubMed ID: 4631138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
    Rizzi G; Isaia GC
    Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics of glibornuride].
    Rentsch G; Schmidt HA; Rieder J
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2209. PubMed ID: 4679250
    [No Abstract]   [Full Text] [Related]  

  • 6. Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.
    Marco J; Valverde I
    Diabetologia; 1973 Sep; ():317-9. PubMed ID: 4204092
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
    Artini D; Abbiati R; Orsini G; Parenti MA; Bloch K; Daturi S; Mandelli V
    Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism of glibornuride in the human].
    Bigler F; Quitt P; Vecchi M; Vetter W
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2191. PubMed ID: 4679249
    [No Abstract]   [Full Text] [Related]  

  • 9. Glipizide versus tolbutamide in maturity-onset diabetes, an open comparative study.
    Fuchs K
    Diabetologia; 1973 Sep; ():351-5. PubMed ID: 4772980
    [No Abstract]   [Full Text] [Related]  

  • 10. [Human pharmacokinetics and metabolism of 14C-labeled gliquidone (AR-DF 26)].
    Kopitar Z
    Arzneimittelforschung; 1975 Sep; 25(9):1455-60. PubMed ID: 1103897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glipizide on a double-meal test in diabetic patients.
    Vailati G; Pagani G; Montini M; Caputo G; Sacchetti G
    Arzneimittelforschung; 1972 Nov; 22(11):1888-9. PubMed ID: 4679061
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical study with glipizide, a new oral antidiabetic drug.
    Persson G
    Diabetologia; 1973 Sep; ():348-50. PubMed ID: 4589635
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with glipizide in the treatment of mostly complicated diabetes.
    Masbernard A; Giudicelli C; Massey J
    Diabetologia; 1973 Sep; ():356-63. PubMed ID: 4772981
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
    Lentini S; Bossini A; Pirola LC
    Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of 14C-glipentide, a new antidiabetic, after oral and intravenous administration.
    Chanal JL; Calmette MT; Khiat M; Rimbau V; Vera A
    Arzneimittelforschung; 1977; 27(4):852-6. PubMed ID: 577463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glipizide, a new oral antidiabetic agent (report of a controlled clinical study in Sweden).
    Johannessen A; Fagerberg SE
    Diabetologia; 1973 Sep; ():339-47. PubMed ID: 4589634
    [No Abstract]   [Full Text] [Related]  

  • 17. An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide.
    De Leeuw I; De Baere H; Decraene P; Lemmens P; Verhaegen H
    Diabetologia; 1973 Sep; ():364-6. PubMed ID: 4204093
    [No Abstract]   [Full Text] [Related]  

  • 18. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
    Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
    Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism of HB 419 in animals].
    Heptner W; Kellner HM; Christ O; Weihrauch D
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1400-4. PubMed ID: 5394460
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.